Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial.

Swati Bhat, Liza Das, Deep Maheshwari, Darshan Badal, Roman Sarkar, Madhu Gupta, Surinder Singh Pandav, Bijaya Kumar Padhi, Sanjay Kumar Bhadada, Michael F Holick, Pinaki Dutta, Naresh Sachdeva, Raman Kumar Marwaha

Journal: The Journal of infection 2023;86(5):e120-e122

PMID: 36889512

Free Full Text on PubMed Central View on PubMed

Abstract

Address: Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.; Department of Community Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.; Department of Ophthalmology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.; Section of Endocrinology, Diabetes, Nutrition & Weight Management, Department of Medicine, School of Medicine, Boston University, Boston, MA, USA.; Departments of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.; Departments of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India. Electronic address: [email protected].; Department of Endocrinology, International Life Sciences Institute (ILSI) and Society of Endocrine Health Care for Elderly, Adolescents and Children (SEHEAC), New Delhi, India. Electronic address: [email protected].

DOI: 10.1016/j.jinf.2023.03.004

Link outs

Free resources

Full Text Sources:

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, ChAdOx1 nCoV-19, Calcifediol, Prospective Studies, Dietary Supplements, Vaccination